| Immunogenicity, Efficacy and Safety Trial of the Convacell Vaccine in Healthy Volunteers Aged 18 Years and Older (NCT05726084) | St. Petersburg Research Institute of Vaccines and Sera | 2022-10-24 |
| Tolerability, Safety and Immunogenicity Trial of the Flu-M Tetra Vaccine in Children (NCT05739474) | St. Petersburg Research Institute of Vaccines and Sera | 2022-01-19 |
| Study of the Immunogenicity, Safety and Tolerability of the Convacell Vaccine. (NCT05156723) | St. Petersburg Research Institute of Vaccines and Sera | 2021-07-19 |
| Tolerability, Safety and Immunogenicity Trial of the FLU-M® Tetra (NCT05308212) | St. Petersburg Research Institute of Vaccines and Sera | 2021-03-04 |
| Trial of Tolerability, Safety and Immunogenicity of the Flu-M Vaccine in Children Between 6 Months and 9 Years Old (NCT05470582) | St. Petersburg Research Institute of Vaccines and Sera | 2021-02-16 |
| Tolerability, Safety and Immunogenicity Trial of the Flu-M® Inactivated Vaccine in Volunteers Aged 18 to 60 Years (NCT05312294) | St. Petersburg Research Institute of Vaccines and Sera | 2020-12-07 |
| Tolerability, Safety and Immunogenicity Trial of the Flu-M Quadro, Tetravalent Inactivated Split Influenza Vaccine (NCT05869201) | St. Petersburg Research Institute of Vaccines and Sera | 2020-10-06 |
| The Objectives of This Study Are Study the Immunogenicity and Safety of the Flu-M [Inactivated Split Influenza Vaccine], vs. the Ultrix® Inactivated Split Influenza Vaccine, in Volunteers Who Are Over 60 Years Old (NCT05089123) | St. Petersburg Research Institute of Vaccines and Sera | 2020-03-03 |
| Tolerability and Reactogenicity Trial of the Recombinant Tuberculosis Allergen in Healthy Volunteers (NCT05398562) | St. Petersburg Research Institute of Vaccines and Sera | 2020-02-13 |
| The Objectives of This Study Are Comparative Assessment of the Tolerability, Safety and Immunogenicity of the Flu-M Vaccine vs. the Ultrix® Vaccine by Single Vaccination of Children Aged 6 to 17 Years. (NCT05317767) | St. Petersburg Research Institute of Vaccines and Sera | 2020-02-10 |
| Trial of Tolerability, Reactogenicity, Safety and Immunogenicity of Flu-M [Inactivated Split Influenza Vaccine] in Pregnant Women (NCT05457894) | St. Petersburg Research Institute of Vaccines and Sera | 2020-01-23 |
| Safety and Reactogenicity Trial of Vaccine for the Prevention of Infections Caused by Haemophilus Influenzae Type b (NCT05401305) | St. Petersburg Research Institute of Vaccines and Sera | 2020-01-14 |
| The Objectives of This Study Are Study the Safety, Reactogenicity and Obtain Preliminary Data on the Immunogenicity of Flu-M Quadro, 4-valent Inactivated Split Influenza Vaccine, in Healthy Volunteers (NCT05152017) | St. Petersburg Research Institute of Vaccines and Sera | 2019-11-16 |
| Trial of the Reactogenicity, Safety and Immunogenicity of the Flu-M Vaccine Manufactured by FSUE SPbSRIVS FMBA (NCT05297994) | St. Petersburg Research Institute of Vaccines and Sera | 2016-10-24 |
| The Objectives of This Study Are Study of the Reactogenicity, Safety and Immunogenicity of Flu-M Inactivated Split Influenza Vaccine in Volunteers Aged 18-60 Years (NCT05126979) | St. Petersburg Research Institute of Vaccines and Sera | 2016-03-09 |